# Safety and Effectiveness Study of Combo Bio-engineered Sirolimus Eluting Stent

> **NCT00967902** · PHASE2 · COMPLETED · sponsor: **OrbusNeich** · enrollment: 180 (actual)

## Conditions studied

- Coronary Artery Lesions

## Interventions

- **DEVICE:** coronary stenting

## Key facts

- **NCT ID:** NCT00967902
- **Lead sponsor:** OrbusNeich
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2011-07
- **Final completion:** 2015-09
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2016-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00967902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00967902, "Safety and Effectiveness Study of Combo Bio-engineered Sirolimus Eluting Stent". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00967902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*